EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot

Elizabeth Lee Lewandrowski, John A Branda, Kent Lewandrowski, Sarah Turbett

American Journal of Clinical Pathology · 2023

DOI: 10.1093/ajcp/aqad007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Elizabeth Lee Lewandrowski und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Division of Clinical Laboratories and Molecular Medicine, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Borrelia, Borrelia burgdorferi, Lyme Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: Quidel Diagnostics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Two-tiered serologic testing for Lyme disease is usually performed using an enzyme-linked immunosorbent assay (ELISA) as the first-tier test. The Quidel Sofia 2 Lyme test is a relatively new lateral flow method to provide more rapid turnaround time. We evaluated its performance in comparison to an established ELISA method. The test can be performed on demand rather than batching assays in a central laboratory.

Methods

We compared the Sofia 2 assay to the Zeus VlsE1/pepC10 IgG/IgM test in a standard two-tiered testing algorithm.

Results

Comparison of the Sofia 2 to the Zeus VlsE1/pepC10 IgG/IgM showed an overall agreement of 89.9% (κ statistic of 0.750, indicating “substantial agreement”). When the tests were followed by immunoblot in a two-tier algorithm, the agreement was 98.9% (κ statistic of 0.973, indicating “almost perfect” agreement).

Conclusions

The Sofia 2 Lyme test performs well when compared with the Zeus VlsE1/pepC10 IgG/IgM in a two-tiered testing algorithm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BorreliaBorrelia burgdorferiLyme DiseaseHumansAntigens, BacterialSensitivity and SpecificityAntibodies, BacterialImmunoglobulin GImmunoglobulin MSerologic TestsEnzyme-Linked Immunosorbent AssayAlgorithms

Stichwörter der Autor:innen

Lyme diseaseLyme serologyMethod comparisonTwo-tiered testing

Substanzen

Antigens, BacterialAntibodies, BacterialImmunoglobulin GImmunoglobulin M

Autor:innen und Institutionen

  • Department of Pathology, Division of Clinical Laboratories and Molecular Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA.
  • Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.

Förderung

  • Quidel Diagnostics

Zitieren

APA

Lewandrowski, E. L., Branda, J. A., Lewandrowski, K., & Turbett, S. (2023). Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqad007

Vancouver

Lewandrowski EL, Branda JA, Lewandrowski K, Turbett S. Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqad007

BibTeX
@article{Lewandrowski2023,
  author = {Lewandrowski, Elizabeth Lee and Branda, John A and Lewandrowski, Kent and Turbett, Sarah},
  title = {Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot},
  journal = {American Journal of Clinical Pathology},
  year = {2023},
  doi = {10.1093/ajcp/aqad007}
}
Kostenlos starten →